Who is sponsoring NCT05753891?

NCT05753891 is sponsored by Henry Ford Health System.

What drugs are being tested in NCT05753891?

Interventions in NCT05753891: Suture Tape Reconstruction.

What condition does NCT05753891 study?

NCT05753891 studies Basilar Thumb Arthritis.

Is NCT05753891 still recruiting?

NCT05753891 is currently terminated. Last updated 17 April 2026.

Are results published for NCT05753891?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2026-04-17 · How we verify

NCT05753891

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trapeziectomy: Internal Brace vs. Ligament Reconstruction (Prospective)

Terminated NA Results posted Last updated 17 April 2026

What this trial tests

NA trial testing Suture Tape Reconstruction in Basilar Thumb Arthritis in 28 participants. Terminated before completion.

Timeline

1 April 2023

Primary endpoint
3 July 2024

3 July 2024

Quick facts

Lead sponsor	Henry Ford Health System
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	28
Start date	1 April 2023
Primary completion	3 July 2024
Estimated completion	3 July 2024
Sites	1 location across United States

Drugs / interventions tested

Suture Tape Reconstruction

Conditions studied

Basilar Thumb Arthritis — all drugs for Basilar Thumb Arthritis →

Sponsor

Henry Ford Health System — full company profile →

Who can join

18 and older, any sex, with Basilar Thumb Arthritis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Pinch Strength Primary · 6 months post procedure

Pinch Strength measurements

Group	Value	95% CI
Carpometacarpal (CMC) Standard Ligament Reconstruction	10	± 2.8

PROMIS-UE Secondary · 6 months post procedure

PROMIS-UE scores are reported as T-scores standardized to the U.S. population (mean 50, SD 10; typical range \~15-61). Higher scores indicate better upper extremity function.

Group	Value	95% CI
Carpometacarpal (CMC) Standard Ligament Reconstruction	36.5	± 7.8

Sponsor's own description

This study seeks to compare two methods of trapeziectomy for basilar thumb arthritis. The first is trapeziectomy with ligament reconstruction and tendon interposition, which means removing the trapezium bone and filling the void with a tendon graft. This is the most commonly used procedure and the control group. The experimental group is trapeziectomy with suture tape suspension of the 1st metacarpal to the 2nd metacarpal. This is using a device called the InternalBrace, produced by Arthrex.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Henry Ford Health System trials

Trials by the same sponsor.

NCT07450183 — Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 · Phase 2 · not yet recruiting
NCT07418853 — Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries · NA · not yet recruiting
NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting
NCT07363525 — Michigan Initial Experience Using Tigertriever for Thrombectomy · not yet recruiting
NCT07530172 — Radioembolization Versus External Radiation Therapy · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05753891 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Henry Ford Health System
Last refreshed: 17 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05753891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing